<code id='2C7E624B76'></code><style id='2C7E624B76'></style>
    • <acronym id='2C7E624B76'></acronym>
      <center id='2C7E624B76'><center id='2C7E624B76'><tfoot id='2C7E624B76'></tfoot></center><abbr id='2C7E624B76'><dir id='2C7E624B76'><tfoot id='2C7E624B76'></tfoot><noframes id='2C7E624B76'>

    • <optgroup id='2C7E624B76'><strike id='2C7E624B76'><sup id='2C7E624B76'></sup></strike><code id='2C7E624B76'></code></optgroup>
        1. <b id='2C7E624B76'><label id='2C7E624B76'><select id='2C7E624B76'><dt id='2C7E624B76'><span id='2C7E624B76'></span></dt></select></label></b><u id='2C7E624B76'></u>
          <i id='2C7E624B76'><strike id='2C7E624B76'><tt id='2C7E624B76'><pre id='2C7E624B76'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:fashion    Page View:5796
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In